Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement – Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceuti
AbbVie has moved to shore up its pipeline following the loss of patent protection for its top-selling drug with a $10.1 billion deal to buy ImmunoGen and its marketed ovar
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
